CoChat

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.

TLR4 signalling via Piezo1 engages and enhances the macrophage mediated host response during bacterial infection

Open access

Abstract

TLR4 signaling plays key roles in the innate immune response to microbial infection. Innate immune cells encounter different mechanical cues in both health and disease to adapt their behaviors. However, the impact of mechanical sensing signals on TLR4 signal-mediated innate immune response remains unclear. Here we show that TLR4 signalling augments macrophage bactericidal activity through the mechanical sensor Piezo1. Bacterial infection or LPS stimulation triggers assembly of the complex of Piezo1 and TLR4 to remodel F-actin organization and augment phagocytosis, mitochondrion-phagosomal ROS production and bacterial clearance and genetic deficiency of Piezo1 results in abrogation of these responses. Mechanistically, LPS stimulates TLR4 to induce Piezo1-mediated calcium influx and consequently activates CaMKII-Mst1/2-Rac axis for pathogen ingestion and killing. Inhibition of CaMKII or knockout of either Mst1/2 or Rac1 results in reduced macrophage bactericidal activity, phenocopying the Piezo1 deficiency. Thus, we conclude that TLR4 drives the innate immune response via Piezo1 providing critical insight for understanding macrophage mechanophysiology and the host response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-23683-y

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Piezo1 is induced and associated with TLR4 upon infection. a Flow cytometry histograms of tdTomato red fluorescence (TMR) or GFP of macrophages (CD11b+F4/80+) from bone marrow (BM), spleen (SP), peritoneal cavity (PC), or bone marrow-derived macrophage (BMDM) of Piezo1P1-tdT mice or BM, SP of Piezo2-EGFP-IRES-Cre mice. b Confocal microscopy of the colocalization (white arrows) of Piezo1 (red), TLR4 (green), and E. coli (blue) in Piezo1P1tdT BMDMs infected with E. coli (MOI, 20). Scale bar = 20 μm. c Confocal microscopy of Piezo1P1tdT or Tlr4−/−Piezo1P1tdT BMDMs incubated with uncoated or LPS-coated latex beads, followed by immunostaining of Piezo1 or TLR4 as indicated; white arrows indicate colocalization of beads (purple), TLR4 (green), and Piezo1 (red). Scale bars, 20 μm. d SIM of the colocalization of Piezo1 (red) and TLR4 (green) in Piezo1P1tdT BMDMs treated with or without LPS (1 μg ml−1) for 30 min; ×16 magnification of areas outlined in the main images are shown next to the main images. Scale bars, 20 μm. e Immunoblot analysis of BMDMs expressing RFP-tagged Piezo1 treated with or without LPS, immunoprecipitated with anti-RFP or control IgG, and analyzed by immunoblot with anti-TLR4 or anti-RFP antibodies; below, immunoblot analysis of total cell lysates (TCL) without immunoprecipitation. Uncropped blots in Source data. f The FRET efficiency from BFP to GFP in the cells co-transfected with BFP-Piezo1 and GFP-TLR4 (n = 15 cells), CFP and YFP (n = 15 cells), or BFP–GFP fusion protein (n = 5 cells), respectively. Data are presented as mean +/− SD. The p-values of two-tailed unpaired Student’s t test are indicated. g Identification of TLR4, Piezo1, and MD2 by mass spectrometry in immunoprecipitation assays using TLR4 antibody in cell lysates of BMDMs untreated or treated with LPS (1 μg ml−1), Yoda1 (5 μM), or both. One experiment representative of three independent experiments with similar results. Source data are provided as a Source data file.
Fig. 1 Piezo1 is induced and associated with TLR4 upon infection. a Flow cytometry histograms of tdTomato red fluorescence (TMR) or GFP of macrophages (CD11b+F4/80+) from bone marrow (BM), spleen (SP), peritoneal cavity (PC), or bone marrow-derived macrophage (BMDM) of Piezo1P1-tdT mice or BM, SP of Piezo2-EGFP-IRES-Cre mice. b Confocal microscopy of the colocalization (white arrows) of Piezo1 (red), TLR4 (green), and E. coli (blue) in Piezo1P1tdT BMDMs infected with E. coli (MOI, 20). Scale bar = 20 μm. c Confocal microscopy of Piezo1P1tdT or Tlr4−/−Piezo1P1tdT BMDMs incubated with uncoated or LPS-coated latex beads, followed by immunostaining of Piezo1 or TLR4 as indicated; white arrows indicate colocalization of beads (purple), TLR4 (green), and Piezo1 (red). Scale bars, 20 μm. d SIM of the colocalization of Piezo1 (red) and TLR4 (green) in Piezo1P1tdT BMDMs treated with or without LPS (1 μg ml−1) for 30 min; ×16 magnification of areas outlined in the main images are shown next to the main images. Scale bars, 20 μm. e Immunoblot analysis of BMDMs expressing RFP-tagged Piezo1 treated with or without LPS, immunoprecipitated with anti-RFP or control IgG, and analyzed by immunoblot with anti-TLR4 or anti-RFP antibodies; below, immunoblot analysis of total cell lysates (TCL) without immunoprecipitation. Uncropped blots in Source data. f The FRET efficiency from BFP to GFP in the cells co-transfected with BFP-Piezo1 and GFP-TLR4 (n = 15 cells), CFP and YFP (n = 15 cells), or BFP–GFP fusion protein (n = 5 cells), respectively. Data are presented as mean +/− SD. The p-values of two-tailed unpaired Student’s t test are indicated. g Identification of TLR4, Piezo1, and MD2 by mass spectrometry in immunoprecipitation assays using TLR4 antibody in cell lysates of BMDMs untreated or treated with LPS (1 μg ml−1), Yoda1 (5 μM), or both. One experiment representative of three independent experiments with similar results. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 2 Piezo1 deficiency impairs phagocytosis and bactericide of macrophage. a, b Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre mice (n = 12 mice per group per experiment) subjected to sublethal CLP. The p-value of mortality Mantel–Cox test is indicated (a), and the bacterial loads (colony forming units, CFU) measured in the lung, liver, spleen, and kidney after CLP induction (Sham group n = 3, CLP group n = 6) (b). c, d Pathogen burden (CFU) in wild-type (c, d) or Piezo1-deficient (d) BMDMs infected with E. coli (MOI, 20) for 0, 90, or 120 min on different stiffness culture matrix, 5 kPa, 35 kPa, or glass (n = 4 independent samples). e Flow cytometry of Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs left uninfected or infected for 20 min at 37 or 4 °C with FITC-labeled E. coli (FITC-E. coli) at a MOI of 20. f Pathogen burden in Piezo1fl/fl and Piezo1fl/fl Lyz2-Cre BMDMs treated with or without Yoda1 (5 μM, 30 min), followed by E. coli infection (MOI, 20) for 0, 90, or 120 min (n = 5 independent samples). Data are presented as mean +/− SD and the p-values of two-tailed unpaired Student’s t test are indicated in (b), (c), (d), and (f). Data are from one experiment representative of three independent experiments with similar results. Source data are provided as a Source data file.
Fig. 2 Piezo1 deficiency impairs phagocytosis and bactericide of macrophage. a, b Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre mice (n = 12 mice per group per experiment) subjected to sublethal CLP. The p-value of mortality Mantel–Cox test is indicated (a), and the bacterial loads (colony forming units, CFU) measured in the lung, liver, spleen, and kidney after CLP induction (Sham group n = 3, CLP group n = 6) (b). c, d Pathogen burden (CFU) in wild-type (c, d) or Piezo1-deficient (d) BMDMs infected with E. coli (MOI, 20) for 0, 90, or 120 min on different stiffness culture matrix, 5 kPa, 35 kPa, or glass (n = 4 independent samples). e Flow cytometry of Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs left uninfected or infected for 20 min at 37 or 4 °C with FITC-labeled E. coli (FITC-E. coli) at a MOI of 20. f Pathogen burden in Piezo1fl/fl and Piezo1fl/fl Lyz2-Cre BMDMs treated with or without Yoda1 (5 μM, 30 min), followed by E. coli infection (MOI, 20) for 0, 90, or 120 min (n = 5 independent samples). Data are presented as mean +/− SD and the p-values of two-tailed unpaired Student’s t test are indicated in (b), (c), (d), and (f). Data are from one experiment representative of three independent experiments with similar results. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 3 Piezo1 is critical for cytoskeleton remodeling and ROS production. a Confocal microscopy of BMDMs were pretreated with DMSO or cytochalasin D (CytD, 2 μM) for 1 h, followed by Yoda1 (5 μM) stimulation for 30 min, then immunostained with anti-F-actin (green) and counterstained with DAPI (blue). Outlined areas are enlarged in top right corners. Scale bars, 20 μm. b The Young’s modulus of BMDMs treated with DMSO vehicle (n = 105), Yoda1 (n = 110), cytoD (n = 110), or Yoda1 plus CytD (n = 108) as indicated in (a). c Confocal microscopy of Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated with LPS (1 μg ml−1), E. coli (MOI, 20), Yoda1 (5 μM) for 30 min, then immunostained with anti-F-actin (green) and counterstained with DAPI (blue); outlined areas are enlarged in top right corners. Scale bars, 20 μm. d The Young’s modulus was determined by AFM for Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated with PBS control (n = 104, 98), Yoda1 (5 μM, n = 82, 81), LPS (1 μg ml−1, n = 55, 105), or E. coli (n = 95, 93). e, f Confocal microscopy of the distribution of mitochondrial networks in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs after infection with GFP–E. coli (green); nuclei were counterstained with DAPI (blue); arrows indicate colocalization of E. coli (green) and Hsp60 (red). Scale bars, 20 μm (e). Pearson’s correlation coefficient values for colocalization of E. coli and Hsp60 in BMDMs. The average Pearson’s correlation coefficients were calculated from eight randomly selected infected cells in each group (n = 8 cells examined) (f). g Flow cytometry analyzing mROS production by Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs stimulated with Yoda1 (5 μM) for 30 min, LPS (1 μg ml−1) for 3 h, or E. coli (MOI, 20) for 1 h, followed by staining with MitoSOX. h Flow cytometry analyzing mROS and cellular ROS production by BMDMs treated with CytD or Yoda1 as indicated in (a). i Pathogen burden in BMDMs pretreated with DMSO or CytD (2 μM, 1 h), followed by Yoda1 (5 μM, 30 min) and then E. coli infection (MOI, 20) for 0, 90, or 120 min (n = 5 independent samples). j Flow cytometry analyzing mROS production by Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated LPS (1 μg ml−1) for 3 h or E. coli (MOI, 20) for 1 h on different stiffness culture matrix of 5 kPa, 35 kPa, or glass, followed by staining with MitoSOX. In b, d, data are represented as boxplots where the middle line is the median, the lower and upper boundaries correspond to the first and third quartiles, whiskers above and below the box indicate the 5th and 95th percentiles, and points above and below the whiskers indicate outliers outside the 5th and 95th percentiles. Data are presented as mean +/− SD (f, i). The p-values of two-way ANOVA in (b), (d), (f) and two-tailed unpaired Student’s t test in (i) are indicated. Data are representative of three independent experiments with similar results. Source data are provided as a Source data file.
Fig. 3 Piezo1 is critical for cytoskeleton remodeling and ROS production. a Confocal microscopy of BMDMs were pretreated with DMSO or cytochalasin D (CytD, 2 μM) for 1 h, followed by Yoda1 (5 μM) stimulation for 30 min, then immunostained with anti-F-actin (green) and counterstained with DAPI (blue). Outlined areas are enlarged in top right corners. Scale bars, 20 μm. b The Young’s modulus of BMDMs treated with DMSO vehicle (n = 105), Yoda1 (n = 110), cytoD (n = 110), or Yoda1 plus CytD (n = 108) as indicated in (a). c Confocal microscopy of Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated with LPS (1 μg ml−1), E. coli (MOI, 20), Yoda1 (5 μM) for 30 min, then immunostained with anti-F-actin (green) and counterstained with DAPI (blue); outlined areas are enlarged in top right corners. Scale bars, 20 μm. d The Young’s modulus was determined by AFM for Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated with PBS control (n = 104, 98), Yoda1 (5 μM, n = 82, 81), LPS (1 μg ml−1, n = 55, 105), or E. coli (n = 95, 93). e, f Confocal microscopy of the distribution of mitochondrial networks in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs after infection with GFP–E. coli (green); nuclei were counterstained with DAPI (blue); arrows indicate colocalization of E. coli (green) and Hsp60 (red). Scale bars, 20 μm (e). Pearson’s correlation coefficient values for colocalization of E. coli and Hsp60 in BMDMs. The average Pearson’s correlation coefficients were calculated from eight randomly selected infected cells in each group (n = 8 cells examined) (f). g Flow cytometry analyzing mROS production by Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs stimulated with Yoda1 (5 μM) for 30 min, LPS (1 μg ml−1) for 3 h, or E. coli (MOI, 20) for 1 h, followed by staining with MitoSOX. h Flow cytometry analyzing mROS and cellular ROS production by BMDMs treated with CytD or Yoda1 as indicated in (a). i Pathogen burden in BMDMs pretreated with DMSO or CytD (2 μM, 1 h), followed by Yoda1 (5 μM, 30 min) and then E. coli infection (MOI, 20) for 0, 90, or 120 min (n = 5 independent samples). j Flow cytometry analyzing mROS production by Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated LPS (1 μg ml−1) for 3 h or E. coli (MOI, 20) for 1 h on different stiffness culture matrix of 5 kPa, 35 kPa, or glass, followed by staining with MitoSOX. In b, d, data are represented as boxplots where the middle line is the median, the lower and upper boundaries correspond to the first and third quartiles, whiskers above and below the box indicate the 5th and 95th percentiles, and points above and below the whiskers indicate outliers outside the 5th and 95th percentiles. Data are presented as mean +/− SD (f, i). The p-values of two-way ANOVA in (b), (d), (f) and two-tailed unpaired Student’s t test in (i) are indicated. Data are representative of three independent experiments with similar results. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 4 Piezo1 modulates cytoskeleton rearrangement via Rac1. a, b Immunoblot analysis of the association of active (GTP-bound) Rac1 and Cdc42 with GST-PAK70–106 in lysates of wild-type BMDMs treated with Yoda1 (5 μM) for 0, 10, or 30 min (a) or the association of active (GTP-bound) Rac1 in lysates of Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated with Yoda1 (5 μM) for 30 min (b); then incubated with GST-PAK70–106 (GST-PAK); CoBlue, staining of GST-PAK70–106 with Coomassie blue. c Flow cytometry analyzing mROS and cellular ROS production of BMDMs from Rac1fl/fl or Rac1fl/fl Lyz2-Cre mice treated with DMSO or Yoda1 (5 μM) for 30 min, followed by staining with MitoSOX or CellROX. d Pathogen burden in Rac1fl/fl or Rac1fl/fl Lyz2-Cre BMDMs treated with or without Yoda1 (5 μM, 30 min), followed by E. coli infection (MOI, 20) for 0, 90, or 120 min (n = 5 independent samples). e Confocal microscopy of Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs treated with control PBS, LPS (1 μg ml−1), or E. coli (MOI, 20) for 30 min, then immunostained with anti-F-actin (green) and counterstained with DAPI (blue); outlined areas are enlarged in top right corners. Scale bars, 20 μm. f The Young’s modulus of Piezo1fl/fl, Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs treated with control PBS (n = 95, 94, 97, or 93) or E. coli (n = 90, 83, 93, or 88) for 30 min; data are represented as boxplots where the middle line is the median, the lower and upper boundaries correspond to the first and third quartiles, whiskers above and below the box indicate the 5th and 95th percentiles, and points above and below the whiskers indicate outliers outside the 5th and 95th percentiles. The p-values of two-way ANOVA are indicated. g, h Confocal microscopy of the distribution of mitochondrial networks in Piezo1fl/fl, Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre, or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs after GFP–E. coli (green) infection; nuclei were counterstained with DAPI (blue) (g); arrows indicate colocalization of E. coli (green) and Hsp60 (red). Scale bars, 20 μm. Pearson’s correlation coefficient values for colocalization of E. coli and Hsp60 in BMDMs. The average Pearson’s correlation coefficients were calculated from eight randomly selected infected cells in each group (n = 8 cells examined) (h). i Flow cytometry analyzing mROS production by Piezo1fl/fl, Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs stimulated with Yoda1 (5 μM) for 30 min, LPS (1 μg ml−1) for 3 h, or E. coli (MOI, 20) for 1 h, followed by staining with MitoSOX. j Pathogen burden (CFU) in Piezo1fl/fl, Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre, or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs infected with GFP–E. coli for 0, 90, or 120 min (n = 5 independent samples). Data are presented as mean +/− SD and the p-values of two-tailed unpaired Student’s t test in (d), (h), (j) are indicated. Data are representative of three independent experiments with similar results. Source data are provided as a Source data file.
Fig. 4 Piezo1 modulates cytoskeleton rearrangement via Rac1. a, b Immunoblot analysis of the association of active (GTP-bound) Rac1 and Cdc42 with GST-PAK70–106 in lysates of wild-type BMDMs treated with Yoda1 (5 μM) for 0, 10, or 30 min (a) or the association of active (GTP-bound) Rac1 in lysates of Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated with Yoda1 (5 μM) for 30 min (b); then incubated with GST-PAK70–106 (GST-PAK); CoBlue, staining of GST-PAK70–106 with Coomassie blue. c Flow cytometry analyzing mROS and cellular ROS production of BMDMs from Rac1fl/fl or Rac1fl/fl Lyz2-Cre mice treated with DMSO or Yoda1 (5 μM) for 30 min, followed by staining with MitoSOX or CellROX. d Pathogen burden in Rac1fl/fl or Rac1fl/fl Lyz2-Cre BMDMs treated with or without Yoda1 (5 μM, 30 min), followed by E. coli infection (MOI, 20) for 0, 90, or 120 min (n = 5 independent samples). e Confocal microscopy of Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs treated with control PBS, LPS (1 μg ml−1), or E. coli (MOI, 20) for 30 min, then immunostained with anti-F-actin (green) and counterstained with DAPI (blue); outlined areas are enlarged in top right corners. Scale bars, 20 μm. f The Young’s modulus of Piezo1fl/fl, Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs treated with control PBS (n = 95, 94, 97, or 93) or E. coli (n = 90, 83, 93, or 88) for 30 min; data are represented as boxplots where the middle line is the median, the lower and upper boundaries correspond to the first and third quartiles, whiskers above and below the box indicate the 5th and 95th percentiles, and points above and below the whiskers indicate outliers outside the 5th and 95th percentiles. The p-values of two-way ANOVA are indicated. g, h Confocal microscopy of the distribution of mitochondrial networks in Piezo1fl/fl, Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre, or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs after GFP–E. coli (green) infection; nuclei were counterstained with DAPI (blue) (g); arrows indicate colocalization of E. coli (green) and Hsp60 (red). Scale bars, 20 μm. Pearson’s correlation coefficient values for colocalization of E. coli and Hsp60 in BMDMs. The average Pearson’s correlation coefficients were calculated from eight randomly selected infected cells in each group (n = 8 cells examined) (h). i Flow cytometry analyzing mROS production by Piezo1fl/fl, Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs stimulated with Yoda1 (5 μM) for 30 min, LPS (1 μg ml−1) for 3 h, or E. coli (MOI, 20) for 1 h, followed by staining with MitoSOX. j Pathogen burden (CFU) in Piezo1fl/fl, Piezo1fl/fl Lyz2-Cre, Rac1G12V Lyz2-Cre, or Piezo1fl/fl Rac1G12V Lyz2-Cre BMDMs infected with GFP–E. coli for 0, 90, or 120 min (n = 5 independent samples). Data are presented as mean +/− SD and the p-values of two-tailed unpaired Student’s t test in (d), (h), (j) are indicated. Data are representative of three independent experiments with similar results. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 5 Mst1 and Mst2 are required for Piezo1-mediated Rac1 activation. a Confocal microscopy of Mst1fl/flMst2fl/fl or Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with the vehicle DMSO, Yoda1 (5 μM), or XMU-MP-1 (3 μM) for 30 min, then immunostained with anti-F-actin (green) and counterstained with DAPI (blue); outlined areas are enlarged in top right corners. Scale bars, 20 μm. b Confocal microscopy of Mst1fl/fl Mst2fl/fl or Mst1fl/fl Mst2fl/fl Lyz-Cre BMDMs treated with the vehicle PBS, LPS (1 μg ml−1), or E. coli (MOI, 20), then immunostained with anti-F-actin (green) and counterstained with or without DAPI (blue); outlined areas are enlarged in top right corners. Scale bars, 20 μm. c The Young’s modulus of Mst1fl/flMst2fl/fl and Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with DMSO vehicle (n = 97, n = 91) or Yoda1 (5 μM) (n = 104, n = 90) for 30 min. Data are represented as boxplots where the middle line is the median, the lower and upper boundaries correspond to the first and third quartiles, whiskers above and below the box indicate the 5th and 95th percentiles, and points above and below the whiskers indicate outliers outside the 5th and 95th percentiles. The p-values of two-way ANOVA are indicated by bracketing. d Immunoblot analysis of the association of active (GTP-bound) Rac1 with GST-PAK70–106 in lysates of Mst1fl/flMst2fl/fl or Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with Yoda1 (5 μM) for 30 min, then incubated with GST-PAK70–106 (GST-PAK); CoBlue, staining of GST-PAK70–106 with Coomassie blue. e Immunoblot analysis of phosphorylated (p)-Mob1, Mob1, Mst1, Mst2, and γ-tubulin in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs stimulated for 0, 10, or 30 min (above lanes) with Yoda1 (5 μM). f, g Immunoblot analysis of phosphorylated p-p38, p-Jnk and p-Mob1, Mob1, and γ-tubulin in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs stimulated with LPS (1 μg ml−1) (f) or E. coli (MOI, 20) (g) for 0, 10, or 30 min. h Flow cytometry analyzing mROS and cellular ROS production of Mst1fl/flMst2fl/fl or Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with DMSO or Yoda1 (5 μM) for 30 min, followed by staining with MitoSOX or CellROX. i Pathogen burden (CFU) in Mst1fl/flMst2fl/fl or Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with or without Yoda1 (5 μM, 30 min), followed by GFP–E. coli infection for 0, 90, or 120 min (n = 5 independent samples). Data are presented as mean +/− SD and the p-values of two-tailed unpaired Student’s t test are indicated. Data are representative of three independent experiments with similar results. Source data are provided as a Source data file.
Fig. 5 Mst1 and Mst2 are required for Piezo1-mediated Rac1 activation. a Confocal microscopy of Mst1fl/flMst2fl/fl or Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with the vehicle DMSO, Yoda1 (5 μM), or XMU-MP-1 (3 μM) for 30 min, then immunostained with anti-F-actin (green) and counterstained with DAPI (blue); outlined areas are enlarged in top right corners. Scale bars, 20 μm. b Confocal microscopy of Mst1fl/fl Mst2fl/fl or Mst1fl/fl Mst2fl/fl Lyz-Cre BMDMs treated with the vehicle PBS, LPS (1 μg ml−1), or E. coli (MOI, 20), then immunostained with anti-F-actin (green) and counterstained with or without DAPI (blue); outlined areas are enlarged in top right corners. Scale bars, 20 μm. c The Young’s modulus of Mst1fl/flMst2fl/fl and Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with DMSO vehicle (n = 97, n = 91) or Yoda1 (5 μM) (n = 104, n = 90) for 30 min. Data are represented as boxplots where the middle line is the median, the lower and upper boundaries correspond to the first and third quartiles, whiskers above and below the box indicate the 5th and 95th percentiles, and points above and below the whiskers indicate outliers outside the 5th and 95th percentiles. The p-values of two-way ANOVA are indicated by bracketing. d Immunoblot analysis of the association of active (GTP-bound) Rac1 with GST-PAK70–106 in lysates of Mst1fl/flMst2fl/fl or Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with Yoda1 (5 μM) for 30 min, then incubated with GST-PAK70–106 (GST-PAK); CoBlue, staining of GST-PAK70–106 with Coomassie blue. e Immunoblot analysis of phosphorylated (p)-Mob1, Mob1, Mst1, Mst2, and γ-tubulin in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs stimulated for 0, 10, or 30 min (above lanes) with Yoda1 (5 μM). f, g Immunoblot analysis of phosphorylated p-p38, p-Jnk and p-Mob1, Mob1, and γ-tubulin in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs stimulated with LPS (1 μg ml−1) (f) or E. coli (MOI, 20) (g) for 0, 10, or 30 min. h Flow cytometry analyzing mROS and cellular ROS production of Mst1fl/flMst2fl/fl or Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with DMSO or Yoda1 (5 μM) for 30 min, followed by staining with MitoSOX or CellROX. i Pathogen burden (CFU) in Mst1fl/flMst2fl/fl or Mst1fl/flMst2fl/fl Lyz2-Cre BMDMs treated with or without Yoda1 (5 μM, 30 min), followed by GFP–E. coli infection for 0, 90, or 120 min (n = 5 independent samples). Data are presented as mean +/− SD and the p-values of two-tailed unpaired Student’s t test are indicated. Data are representative of three independent experiments with similar results. Source data are provided as a Source data file.CC BY · PubMed Central
Fig. 6 Piezo1 activates kinases Mst1/2 through CaMKII. a Calcium influx over time in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated with Yoda1 (5 μM) or LPS (1 μg ml−1). b Immunoblot analysis of phosphorylated (p)-Mob1, Mob1, Mst1, Mst2, and GAPDH in BMDMs pretreated with DMEM with (normal) or without calcium (no Ca2+) for 2 h and then treated with Yoda1 (5 μM) for 0, 10, 30 min. c Immunoblot analysis of p-Mob1, Mob1, and GAPDH in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs cells pretreated with BAPTA-AM (20 μM) for 2 h, then followed by Yoda1 stimulation for 0, 10, or 30 min. d, e Immunoblot analysis of phosphorylated p-Mob1, Mob1, Mst1, Mst2, and GAPDH in BMDMs pretreated with BAPTA-AM (20 μM) for 2 h and then treated with Yoda1 (5 μM) for 0, 10, 30 min (d), or pretreated with BAPTA-AM (0, 5, 10, 20, 50 μM) for 2 h and then treated with Yoda1 (5 μM) for 30 min (e). f Immunoblot analysis of p-Mob1, Mob1, Mst1, and GAPDH in BMDMs pretreated for 2 h with PKC inhibitor (Bisindolylmaleimide I, 4 μM), FAK inhibitor (TAE226, 10 μM), CaMKs inhibitor (KN-62, 10 μM), then followed by Yoda1 (5 μM) stimulation for 30 min. g Immunoblot analysis of 293T cells expressing various combinations of HA-tagged Mst1 and Flag-tagged CaMKI, CaMKII, or CaMKIV, immunoprecipitated with anti-Flag and analyzed by immunoblot with anti-HA (α-HA) or anti-Flag (α-Flag); below, immunoblot analysis of total cell lysates (TCL) without immunoprecipitation. h Phos-tag and SDS-PAGE analysis of HA-tagged kinase-inactive Mst1 (Mst1K/R) expressed together with Flag-tagged CaMKII and/or HA-tagged Calmodulin-3 (HA-CALM3) in 293T cells by immunobloting with anti-HA (α-HA) or anti-Flag (α-Flag) antibodies. i BMDMs Immunoblot analysis of the association of active (GTP-bound) Rac1 with GST-PAK70–106 in lysates of BMDMs pretreated with TFA (10 μM) for 2 h and then treated with Yoda1 (5 μM) for 30 min. j The Young’s modulus of BMDMs treated with DMSO vehicle (n = 97), TFA (10 μM) (n = 99), Yoda1 (5 μM) (n = 90), or TFA plus Yoda1 (n = 90) as in (h). Data are represented as boxplots where the middle line is the median, the lower and upper boundaries correspond to the first and third quartiles, whiskers above and below the box indicate the 5th and 95th percentiles, and points above and below the whiskers indicate outliers outside the 5th and 95th percentiles. k mROS and cellular ROS production by BMDMs with the indicated treatment, followed by staining with MitoSOX or CellROX. l, m BMDMs pretreated with DMSO or TFA (10 μM) for 2 h and then infection with GFP–E. coli (MOI, 20) (green). Confocal microscopy of the distribution of mitochondrial networks after 30 min of bacterial infection, nuclei were counterstained with DAPI (blue); arrows indicate colocalization of E. coli (green) and Hsp60 (red) (l), Pearson’s correlation coefficient values for colocalization of E. coli and Hsp60 in BMDMs. The average Pearson’s correlation coefficients were calculated from eight randomly selected infected cells in each group (n = 8 cells examined) (m). Scale bars, 20 μm. n Pathogen burden (CFU) in BMDMs treated as indicated, followed by infection with GFP–E. coli for 0, 90, or 120 min (n = 5 independent samples). Data are presented as mean +/− SD (m, n). The p-values of two-way ANOVA in (j), (m) and two-tailed unpaired Student’s t test in (n) are indicated by bracketing. Data are representative of three independent experiments with similar results. Source data are provided as a Source data file.
Fig. 6 Piezo1 activates kinases Mst1/2 through CaMKII. a Calcium influx over time in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs treated with Yoda1 (5 μM) or LPS (1 μg ml−1). b Immunoblot analysis of phosphorylated (p)-Mob1, Mob1, Mst1, Mst2, and GAPDH in BMDMs pretreated with DMEM with (normal) or without calcium (no Ca2+) for 2 h and then treated with Yoda1 (5 μM) for 0, 10, 30 min. c Immunoblot analysis of p-Mob1, Mob1, and GAPDH in Piezo1fl/fl or Piezo1fl/fl Lyz2-Cre BMDMs cells pretreated with BAPTA-AM (20 μM) for 2 h, then followed by Yoda1 stimulation for 0, 10, or 30 min. d, e Immunoblot analysis of phosphorylated p-Mob1, Mob1, Mst1, Mst2, and GAPDH in BMDMs pretreated with BAPTA-AM (20 μM) for 2 h and then treated with Yoda1 (5 μM) for 0, 10, 30 min (d), or pretreated with BAPTA-AM (0, 5, 10, 20, 50 μM) for 2 h and then treated with Yoda1 (5 μM) for 30 min (e). f Immunoblot analysis of p-Mob1, Mob1, Mst1, and GAPDH in BMDMs pretreated for 2 h with PKC inhibitor (Bisindolylmaleimide I, 4 μM), FAK inhibitor (TAE226, 10 μM), CaMKs inhibitor (KN-62, 10 μM), then followed by Yoda1 (5 μM) stimulation for 30 min. g Immunoblot analysis of 293T cells expressing various combinations of HA-tagged Mst1 and Flag-tagged CaMKI, CaMKII, or CaMKIV, immunoprecipitated with anti-Flag and analyzed by immunoblot with anti-HA (α-HA) or anti-Flag (α-Flag); below, immunoblot analysis of total cell lysates (TCL) without immunoprecipitation. h Phos-tag and SDS-PAGE analysis of HA-tagged kinase-inactive Mst1 (Mst1K/R) expressed together with Flag-tagged CaMKII and/or HA-tagged Calmodulin-3 (HA-CALM3) in 293T cells by immunobloting with anti-HA (α-HA) or anti-Flag (α-Flag) antibodies. i BMDMs Immunoblot analysis of the association of active (GTP-bound) Rac1 with GST-PAK70–106 in lysates of BMDMs pretreated with TFA (10 μM) for 2 h and then treated with Yoda1 (5 μM) for 30 min. j The Young’s modulus of BMDMs treated with DMSO vehicle (n = 97), TFA (10 μM) (n = 99), Yoda1 (5 μM) (n = 90), or TFA plus Yoda1 (n = 90) as in (h). Data are represented as boxplots where the middle line is the median, the lower and upper boundaries correspond to the first and third quartiles, whiskers above and below the box indicate the 5th and 95th percentiles, and points above and below the whiskers indicate outliers outside the 5th and 95th percentiles. k mROS and cellular ROS production by BMDMs with the indicated treatment, followed by staining with MitoSOX or CellROX. l, m BMDMs pretreated with DMSO or TFA (10 μM) for 2 h and then infection with GFP–E. coli (MOI, 20) (green). Confocal microscopy of the distribution of mitochondrial networks after 30 min of bacterial infection, nuclei were counterstained with DAPI (blue); arrows indicate colocalization of E. coli (green) and Hsp60 (red) (l), Pearson’s correlation coefficient values for colocalization of E. coli and Hsp60 in BMDMs. The average Pearson’s correlation coefficients were calculated from eight randomly selected infected cells in each group (n = 8 cells examined) (m). Scale bars, 20 μm. n Pathogen burden (CFU) in BMDMs treated as indicated, followed by infection with GFP–E. coli for 0, 90, or 120 min (n = 5 independent samples). Data are presented as mean +/− SD (m, n). The p-values of two-way ANOVA in (j), (m) and two-tailed unpaired Student’s t test in (n) are indicated by bracketing. Data are representative of three independent experiments with similar results. Source data are provided as a Source data file.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Cited by

See all 308

Metadata

Authors
Geng, J., Shi, Y., Zhang, J., Yang, B., Wang, P., Yuan, W., Zhao, H., Li, J., Qin, F., Hong, L., Xie, C., Deng, X., Sun, Y., Wu, C., Chen, L., & Zhou, D.
Affiliations
  • Xiamen University (CN)
  • Second Affiliated Hospital of Xi'an Jiaotong University (CN)
  • Peking University (CN)
Corresponding author
  • Chen, Lanfen
  • Zhou, Dawang
Venue
Nature Communications
Published
2021-06-10
Volume
12
Issue
1
Pages
3519-3519
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3166797325
Cited by
290
References
65
Citations by year
2026: 72 · 2025: 76 · 2024: 70 · 2023: 46 · 2022: 24 · 2021: 2
FWCI
13.34
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (31625010, 2017YFA0504502, 81830046, 81902797, 32070891, 82021003, 81790254, U1905208)
  • Peking University
  • Xiamen University (20720180047)
  • Recruitment Program of Global Experts
  • Fundamental Research Funds for the Central Universities (20720180047)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › Invertebrate Immune Response Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
Keywords
TLR4 signaling, Piezo1, macrophages, mechanical sensing, innate immunity, bacterial infection, lipopolysaccharide, phagocytosis, F-actin reorganization, mitochondrial reactive oxygen species, calcium influx, CaMKII, MST1/2, Rac1, host defense
MeSH terms
Serine-Threonine Kinase 3, Hippo Kinases, Actins, Animals, Bacterial Infections, Calcium, Cytoskeleton, Escherichia coli Infections, Humans, Immunity, Innate, Ion Channels, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Neuropeptides, Phagocytosis, Phagosomes, Proto-Oncogene Proteins, Signal Transduction, Hepatocyte Growth Factor, Protein Serine-Threonine Kinases, Reactive Oxygen Species, rac1 GTP-Binding Protein, Fluorescence Resonance Energy Transfer, Toll-Like Receptor 4, Mice, Calcium-Calmodulin-Dependent Protein Kinase Type 2, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TLR4 signalling via Piezo1 engages and enhances the macrophage mediated host response during bacterial infection. https://app.cochat.ai/papers/10.1038/s41467-021-23683-y
The paper
Geng, J., Shi, Y., Zhang, J., Yang, B., Wang, P., Yuan, W., Zhao, H., Li, J., Qin, F., Hong, L., Xie, C., Deng, X., Sun, Y., Wu, C., Chen, L., & Zhou, D. (2021). TLR4 signalling via Piezo1 engages and enhances the macrophage mediated host response during bacterial infection. Nature Communications. https://doi.org/10.1038/s41467-021-23683-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.